Condition: Abdominal Cancer · Sponsor: Australasian Gastro-Intestinal Trials Group
The aim of this study is to investigate the effect of MRI-guided adaptive stereotactic radiotherapy on local control, survival, and toxicity in the treatment of oligometastatic cancer to the abdomen.
This description comes directly from the study's public registry record.
Sukanya Sathyamurthie · +61 2 7208 2719 · sukanya@gicancer.org.au
Sandra Bahamad · +61 2 7208 2714 · sandra@gicancer.org.au
Always discuss trial participation with your own doctor first.
| GenesisCare - St Vincent's Sydney | Darlinghurst, New South Wales, Australia | Recruiting |
| Austin Health | Melbourne, Victoria, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06604533